Nimotop · DIN 02325926 · 30 mg · tablet
Limited Use, Reason for Use code 42, 43 requiredMarketed · checked October 5, 2026
StatusLimited Use, Reason for Use code 42, 43 required
Write on scriptone applicable Reason for Use code, 42 or 43 (criteria below)
Patient paysNot calculated: no patient details entered. Add age and coverage above to see what this patient would pay.
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
Ontario Limited Use criteria, code 42, 43
Reason for Use code 42
As adjunctive therapy to improve the neurologic outcome following subarachnoid haemorrhage during the acute management period (within 4 days of haemorrhage).
Coverage limit:
LU Authorization Period: 1 year
Reason for Use code 43
As prophylaxis of ischemia if surgery is delayed.
Coverage limit:
LU Authorization Period: 1 year
No interchangeable product listed in the Ontario extract
Nimotop · DIN 02325926
Manufacturer: Laboratoire X.O; listing date 2011-10-25
Health Canada: Marketed since 2025-08-18 · brand NIMOTOP · ATC C08CA06 NIMODIPINE · form Tablet · route Oral · ingredients NIMODIPINE 30 MG · company Laboratoire x.0 · schedule Prescription
Nimotop: Formulary list price $10.30 per unit (the source does not state the unit; exact figure $10.3006). What the ministry pays, not the patient.
Ministry pays: $10.3006 per source unit.
Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02325926)
Source record
DIN 02325926: Nimotop
Raw flags: chronicUseMed=Y, sec12=Y, sec3=Y
Item: 241200095; group id 368; item number 0859; lccId 00215; manufacturer id LXO
Source form: Tab; strength: 30mg
Recorded listing: Limited Use: paid only with a Reason for Use code and the criteria below; chronic-use medication (100-day supply rule, dispensing-fee limit)
Source prices (unrounded): $10.3006; ministry $10.3006
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02325926
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=81127
Shortage status: avoided shortage; reports as of October 6, 2026 (Health Product Shortages Canada)
Source: https://healthproductshortages.ca/search?term=02325926
Shortage record checked October 6, 2026